Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Vojinovic, Jelena (6603423836)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Linear IgA dermatosis of the childhood—Report of an amoxicillin-induced case
    (2020)
    Stamenkovic, Hristina Momcilo (15133339500)
    ;
    Lazarevic, Dragana (57190069826)
    ;
    Stankovic, Tatjana (57196829668)
    ;
    Vojinovic, Jelena (6603423836)
    ;
    Lekic, Branislav (56092444000)
    ;
    Marinkovic, Aleksandar (57212198288)
    ;
    Bosic, Martina (56606207600)
    Linear IgA dermatosis (LAD) is a rare autoimmune disorder in children. A 9-year-old boy was presented with blisters on the intact skin (face, body, arms, hands, soles, perigenital and perianal area) after amoxicillin treatment. Systemic corticosteroids and dapsone treatment for 6 weeks was successful. Clinical and immunofluorescence examinations are most important for differentiation of LAD and other drug-induced bullous dermatoses. They enable an early introduction of proper therapy. © 2019 Wiley Periodicals, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The OMERACT ultrasound group: A report from the OMERACT 2016 meeting and perspectives
    (2017)
    Terslev, Lene (55949307900)
    ;
    Iagnocco, Annamaria (6603972277)
    ;
    Bruyn, George A.W. (7006486448)
    ;
    Naredo, Esperanza (6602827091)
    ;
    Vojinovic, Jelena (6603423836)
    ;
    Collado, Paz (7004139223)
    ;
    Damjanov, Nemanja (8503557800)
    ;
    Filer, Andrew (6603511236)
    ;
    Filippou, Georgios (57877288000)
    ;
    Finzel, Stephanie (36703920200)
    ;
    Gandjbakhch, Frederique (23567463900)
    ;
    Ikeda, Kei (7404891581)
    ;
    Keen, Helen I. (15051832900)
    ;
    Kortekaas, Marion C. (36944035400)
    ;
    Magni-Manzoni, Silvia (6602281787)
    ;
    Ohrndorf, Sarah (13205334300)
    ;
    Pineda, Carlos (55989786100)
    ;
    Ravagnani, Viviana (23100930700)
    ;
    Richards, Bethan (19737986700)
    ;
    Sahbudin, Ilfita (56731080400)
    ;
    Schmidt, Wolfgang A. (7404056149)
    ;
    Siddle, Heidi J. (26650180700)
    ;
    Stoenoiu, Maria S. (6602649826)
    ;
    Szkudlarek, Marcin (6603855651)
    ;
    Tzaribachev, Nikolay (16837459300)
    ;
    D'Agostino, Maria-Antonietta (26643055600)
    Objective: To provide an update from the Outcome Measures in Rheumatology (OMERACT) Ultrasound Working Group on the progress for defining ultrasound (US) minimal disease activity threshold at joint level in rheumatoid arthritis (RA) and for standardization of US application in juvenile idiopathic arthritis (JIA). Methods: For minimal disease activity, healthy controls (HC) and patients with early arthritis (EA) who were naive to disease-modifying antirheumatic drugs were recruited from 2 centers. US was performed of the hands and feet, and scored semiquantitatively (0-3) for synovial hypertrophy (SH) and power Doppler (PD). Synovial effusion (SE) was scored a binary variable. For JIA, a Delphi approach and subsequent validation in static images and patient-based exercises were used to developed preliminary definitions for synovitis and a scoring system. Results: For minimal disease activity, 7% HC had at least 1 joint abnormality versus 30% in the EA group. In HC, the findings of SH and PD were predominantly grade 1 whereas all grades were seen in the EA cohort, but SE was rare. In JIA, synovitis can be diagnosed based on B-mode findings alone because of the presence of physiological vascularization. A semiquantitative scoring system (0-3) for synovitis for both B-mode and Doppler were developed in which the cutoff between Doppler grade 2 and grade 3 was 30%. Conclusion: The first step has been taken to define the threshold for minimal disease activity in RA by US and to define and develop a scoring system for synovitis in JIA. Further steps are planned for the continuous validation of US in these areas. The Journal of Rheumatology Copyright © 2017. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The OMERACT ultrasound group: A report from the OMERACT 2016 meeting and perspectives
    (2017)
    Terslev, Lene (55949307900)
    ;
    Iagnocco, Annamaria (6603972277)
    ;
    Bruyn, George A.W. (7006486448)
    ;
    Naredo, Esperanza (6602827091)
    ;
    Vojinovic, Jelena (6603423836)
    ;
    Collado, Paz (7004139223)
    ;
    Damjanov, Nemanja (8503557800)
    ;
    Filer, Andrew (6603511236)
    ;
    Filippou, Georgios (57877288000)
    ;
    Finzel, Stephanie (36703920200)
    ;
    Gandjbakhch, Frederique (23567463900)
    ;
    Ikeda, Kei (7404891581)
    ;
    Keen, Helen I. (15051832900)
    ;
    Kortekaas, Marion C. (36944035400)
    ;
    Magni-Manzoni, Silvia (6602281787)
    ;
    Ohrndorf, Sarah (13205334300)
    ;
    Pineda, Carlos (55989786100)
    ;
    Ravagnani, Viviana (23100930700)
    ;
    Richards, Bethan (19737986700)
    ;
    Sahbudin, Ilfita (56731080400)
    ;
    Schmidt, Wolfgang A. (7404056149)
    ;
    Siddle, Heidi J. (26650180700)
    ;
    Stoenoiu, Maria S. (6602649826)
    ;
    Szkudlarek, Marcin (6603855651)
    ;
    Tzaribachev, Nikolay (16837459300)
    ;
    D'Agostino, Maria-Antonietta (26643055600)
    Objective: To provide an update from the Outcome Measures in Rheumatology (OMERACT) Ultrasound Working Group on the progress for defining ultrasound (US) minimal disease activity threshold at joint level in rheumatoid arthritis (RA) and for standardization of US application in juvenile idiopathic arthritis (JIA). Methods: For minimal disease activity, healthy controls (HC) and patients with early arthritis (EA) who were naive to disease-modifying antirheumatic drugs were recruited from 2 centers. US was performed of the hands and feet, and scored semiquantitatively (0-3) for synovial hypertrophy (SH) and power Doppler (PD). Synovial effusion (SE) was scored a binary variable. For JIA, a Delphi approach and subsequent validation in static images and patient-based exercises were used to developed preliminary definitions for synovitis and a scoring system. Results: For minimal disease activity, 7% HC had at least 1 joint abnormality versus 30% in the EA group. In HC, the findings of SH and PD were predominantly grade 1 whereas all grades were seen in the EA cohort, but SE was rare. In JIA, synovitis can be diagnosed based on B-mode findings alone because of the presence of physiological vascularization. A semiquantitative scoring system (0-3) for synovitis for both B-mode and Doppler were developed in which the cutoff between Doppler grade 2 and grade 3 was 30%. Conclusion: The first step has been taken to define the threshold for minimal disease activity in RA by US and to define and develop a scoring system for synovitis in JIA. Further steps are planned for the continuous validation of US in these areas. The Journal of Rheumatology Copyright © 2017. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback